Latest stories on CABA
Cabaletta Bio stock maintains Buy rating at TD Cowen on trial progress
Investing.com Analyst Ratings61 · neutralanalyst
Why is Cabaletta Bio stock sliding today?
Investing.com Markets34 · bearishgeneral
Cabaletta Bio GAAP EPS of -$0.34 beats by $0.04
Seeking Alpha56 · neutralearnings
Cabaletta Bio, Inc. (CABA) files 8-K
SEC 8-K50 · neutralgeneral
Cabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
Business Insider55 · neutralgeneral
Cabaletta Bio: The Market Sold The EULAR News, I'm Buying
Seeking Alpha67 · bullishproduct/pr
How Cabaletta Bio (CABA) Is Turning Rese-cel Enrollment and New Financing Into a Clearer Autoimmune Cell Therapy Setup
Yahoo Top67 · bullishproduct/pr
Cabaletta Bio, Inc. (CABA) files 8-K
SEC 8-K50 · neutralgeneral
Cabaletta Bio, Inc. (CABA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha56 · neutralgeneral
Cabaletta Bio Inc. (CABA) A Top Penny Stock Eyeing Rese-Cel Commercial Launch for Autoimmune Diseases
Yahoo Finance58 · neutralproduct/pr
Cabaletta Bio Highlights Rese-cel Data and Pivotal Path
TipRanks63 · neutralproduct/pr
Cabaletta Bio Q1 Earnings: More Positive Data Suggests CAR-T Can Work In Autoimmune
Seeking Alpha63 · neutralearnings